SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,343,000 | +40.8% | 149,835 | 0.0% | 0.05% | +18.6% |
Q1 2020 | $954,000 | -23.9% | 149,835 | 0.0% | 0.04% | -8.5% |
Q4 2019 | $1,254,000 | -3.6% | 149,835 | +24.1% | 0.05% | -11.3% |
Q2 2019 | $1,301,000 | -43.5% | 120,768 | -50.0% | 0.05% | -43.6% |
Q1 2019 | $2,304,000 | -16.9% | 241,538 | 0.0% | 0.09% | -21.0% |
Q4 2018 | $2,773,000 | -4.8% | 241,538 | +40.5% | 0.12% | +12.3% |
Q3 2018 | $2,914,000 | +70.3% | 171,889 | +42.6% | 0.11% | +63.1% |
Q2 2018 | $1,711,000 | +105.6% | 120,512 | +60.7% | 0.06% | +116.7% |
Q2 2015 | $832,000 | -92.2% | 75,000 | -89.0% | 0.03% | -92.9% |
Q1 2015 | $10,648,000 | +3.1% | 679,100 | 0.0% | 0.42% | -12.6% |
Q4 2014 | $10,329,000 | +27.7% | 679,100 | -9.5% | 0.48% | +27.4% |
Q3 2014 | $8,090,000 | +339.9% | 750,100 | +523.0% | 0.38% | +124.3% |
Q2 2014 | $1,839,000 | +114.6% | 120,400 | +154.0% | 0.17% | +96.5% |
Q1 2014 | $857,000 | – | 47,400 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |